As immunisation emerges as the world’s primary weapon to combat COVID-19, much more work is needed to improve electricity access so vaccines can be refrigerated.
Articles on COVID-19 vaccine rollout
Displaying 61 - 80 of 87 articles
Allowing people to discuss their concerns one-on-one has been shown the improve vaccine uptake.
The government should be explicit about what proportion of the population will need to be vaccinated to warrant border reopening. Australians could then measure progress towards that goal.
Several countries on the continent had introduced COVID-19 vaccination by early March 2021.
Prime Minister Scott Morrison’s strong ratings in the Newspoll and Essential poll suggest the slow vaccine rollout and anger among women might not be hurting the government yet.
Is Australia behind on its rollout of the COVID-19 vaccine? Yes. Will it catch up? Most likely, yes. But there are perils in trying to go too fast, and in overpromising on deadlines.
There is a difference between people who deliberately seek out vaccines outside the system, and those who are offered them because they’re about to expire.
Stockpiles of this vaccine are going unused in France and Germany, and unfounded criticism of it may be partly to blame.
For those who are socially deprived, vulnerability to COVID-19 will arise at an earlier age.
Real-world studies of vaccines aren’t directly comparable with clinical trials, but their results are still good news.
South Africa is aiming for 67% coverage, which translates to about 40 million people by the end of 2021.
Most of us don’t know yet when or where we’ll receive our COVID vaccination. But particularly as there’s a risk of scams, it’s important to be clear on how this process will (and won’t) play out.
Two experts explain why the UK’s vaccine programme has been a success, while abroad China, Russia and India use vaccine supplies to increase their soft power.
Good decisions and investment have built a strong supply chain, while various experts have helped with distribution.
Two residents in a Brisbane aged-care home were given a higher dose of the Pfizer vaccine than recommended. Here’s what might have happened – and how we can reduce the risk it will happen again.
Australia’s keenly awaited COVID vaccine rollout begins today. So how will it work, and will the vaccine be the end of all our coronavirus-related problems?
The UK has given around 25% of its population a first dose, but across the world fewer than 3% of people have received a vaccine.
For now, the UK will continue with its age-based prioritisation, but there’s a case for key workers and the socially disadvantaged to start feeding into the vaccine queue.
The arrival of COVID-19 vaccines has raised hope for an end to the pandemic. Hopefully that’s true, but there are variables. Here are some factors that could affect the success of the vaccine rollout.
Behind Canada’s current COVID-19 vaccine shortage is a decades-long tale of unheeded warnings, missed opportunities and dismantled resources that was never going to end well.
Top contributors
-
General Practitioner, PhD Candidate, Bond University
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Deputy Director of the HUMLOG (Humanitarian Logistics and Supply Chain Management Research) Institute, Hanken School of Economics
-
Professor of Epidemiology Healthcare Infection and Infectious Diseases Control, UNSW
-
Professor, The Children's Hospital at Westmead Clinical School and Sydney Infectious Diseases Institute, University of Sydney
-
Associate Professor, Epidemiology, Deakin University
-
Adjunct Associate Professor, Menzies Centre for Health Policy and Economics, University of Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Paediatrics and vaccinologist, Royal Childrens Hospital, University of Melbourne and Murdoch Childrens Research Institute (MCRI); Associate Dean International, University of Melbourne, Murdoch Children's Research Institute
-
Research Fellow in Applied Moral Philosophy, University of Oxford
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW
-
Adjunct Professor: Department Internal Medicine, University of Pretoria
-
Research Fellow, Vaccine Uptake Group, Murdoch Children's Research Institute
-
Senior Associate, Grattan Institute